ASCEND BY NTHRYS
Research Abroad Products

Molecular Oncology Project Topics

Browse all focused areas across all project categories under this field.

Showing 217–220 of 220 project topics
Multi-Biomarker Immunotherapy Response Prediction Engine
A proprietary analytics tool combining genomic, transcriptomic, and immune profiling data to predict patient response to checkpoint inhibitor therapies before treatment begins. This supports precision medicine pricing models and licensing agreements with pharmaceutical manufacturers and cancer centers globally.
Biotech Innovation in Oncology Diagnostics Click to view more details →
RNA-Based Cancer Early Detection Screening Kit
A commercial diagnostic kit utilizing circulating RNA biomarkers to detect multiple cancer types in asymptomatic populations with clinical-grade sensitivity and specificity. Revenue streams include direct-to-consumer sales, partnership licensing with diagnostic laboratories, and institutional bulk purchasing agreements.
Biotech Innovation in Oncology Diagnostics Click to view more details →
Epigenetic Methylation Profiling Commercial Testing Service
A CLIA-certified laboratory service offering comprehensive DNA methylation analysis for cancer subtype classification, prognosis assessment, and treatment selection guidance. This generates high-margin diagnostic revenue per test while establishing customer lock-in through proprietary reporting and clinical interpretation services.
Biotech Innovation in Oncology Diagnostics Click to view more details →
Genomic Tumor Burden Quantification and Reporting Platform
An integrated software platform that quantifies and tracks somatic mutation burden across serial patient samples to monitor treatment efficacy and disease progression in real time. The platform captures value through per-test processing fees, data analytics licensing, and longitudinal patient monitoring subscriptions.
Biotech Innovation in Oncology Diagnostics Click to view more details →